Das Klinikum Ernst von Bergmann ist ein kommunales Krankenhaus in der brandenburgischen Landeshauptstadt Potsdam. Es wird in der Form einer gemeinnützigen GmbH betrieben und ist, der Bettenzahl zufolge, nach dem Carl-Thiem-Klinikum Cottbus das zweitgrößte Schwerpunktkrankenhaus im Land Brandenburg.

During the past decade, Klinikum Ernst von Bergmann conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Ernst von Bergmann" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "European Society for Blood and Marrow Transplantation" with 2 trials sponsored and "MedSIR" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Ernst von Bergmann" #1 collaborator was "German Research Foundation" with 2 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Ernst von Bergmann" are "Chronic Lymphocytic Leukemia" (4 trials), "Lymphoma" (4 trials), "Breast Neoplasms" (2 trials), "Colorectal Cancer" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "Klinikum Ernst von Bergmann" in a lesser frequency.

Most popular intervention types in "Klinikum Ernst von Bergmann" are "Drug" (32 trials), "Biological" (8 trials), "Device" (5 trials), "Radiation" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Ernst von Bergmann" are 39 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Ernst von Bergmann". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Klinikum Ernst von Bergmann, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Ernst von Bergmann, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".